Amgen (AMGN) Dividends Paid - Common (2011 - 2026)
Amgen (AMGN) posted Dividends Paid - Common of $1.4 billion for Q2 2026, little changed on a QoQ basis from $1.4 billion in Q1 2026, and up 6.41% year-over-year from $1.3 billion in Q2 2025.
Analysis
Amgen (AMGN) Dividends Paid - Common (2011 - 2026) Analysis & Trends
Amgen has reported Dividends Paid - Common for 16 years, with the latest figure at $1.4 billion in Q2 2026.
- On a quarterly basis, Dividends Paid - Common rose 6.41% year-over-year to $1.4 billion in Q2 2026; TTM through Jun 2026 was $5.3 billion, a 6.25% increase from a year earlier, with the FY2025 full-year figure at $5.1 billion, up 6.04% from the prior year.
- Dividends Paid - Common was $1.4 billion for Q2 2026 at Amgen, roughly flat from $1.4 billion in the prior quarter.
- The five-year high for Dividends Paid - Common was $1.4 billion in Q2 2026, with the low at $1.0 billion in Q2 2022.
- Average Dividends Paid - Common over 5 years is $1.2 billion, with a median of $1.2 billion recorded in 2024.
- The sharpest annual moves came in 2022 and 2023: Dividends Paid - Common advanced 2.98% in 2022, then advanced 9.83% in 2023.
- Over 5 years, Dividends Paid - Common stood at $1.0 billion in 2022, then increased by 9.62% to $1.1 billion in 2023, then rose by 5.7% to $1.2 billion in 2024, then advanced by 6.47% to $1.3 billion in 2025, then grew by 6.16% to $1.4 billion in 2026.
- The last three Dividends Paid - Common figures came in at $1.4 billion (Q2 2026), $1.4 billion (Q1 2026), and $1.3 billion (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dividends Paid - Common (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 203.97 Bn | 189.99 Bn | 7.24 Bn | 1.36 Bn |
| 2 | Gilead Sciences | 178.74 Bn | 175.56 Bn | 6.22 Bn | 1.03 Bn |
| 3 | Vertex Pharmaceuticals | 130.73 Bn | 122.88 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 80.42 Bn | 72.42 Bn | 3.93 Bn | 96.80 Mn |
| 5 | Argenx Se | 60.40 Bn | 55.21 Bn | 1.37 Bn | - |
| 6 | Moderna | 57.65 Bn | 52.52 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 33.37 Bn | 30.07 Bn | 992.69 Mn | - |
| 8 | Biogen | 32.15 Bn | 30.86 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 29.58 Bn | 29.58 Bn | 1.16 Mn | - |
| 10 | Insmed | 28.06 Bn | 26.90 Bn | 358.27 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.36 Bn |
| Mar 31, 2026 | 1.36 Bn |
| Dec 31, 2025 | 1.28 Bn |
| Sep 30, 2025 | 1.28 Bn |
| Jun 30, 2025 | 1.28 Bn |
| Mar 31, 2025 | 1.28 Bn |
| Dec 31, 2024 | 1.21 Bn |
| Sep 30, 2024 | 1.21 Bn |
| Jun 30, 2024 | 1.21 Bn |
| Mar 31, 2024 | 1.21 Bn |
| Dec 31, 2023 | 1.14 Bn |
| Sep 30, 2023 | 1.14 Bn |
| Jun 30, 2023 | 1.14 Bn |
| Mar 31, 2023 | 1.14 Bn |
| Dec 31, 2022 | 1.04 Bn |
| Sep 30, 2022 | 1.04 Bn |
| Jun 30, 2022 | 1.04 Bn |
| Mar 31, 2022 | 1.08 Bn |
| Dec 31, 2021 | 990.00 Mn |
| Sep 30, 2021 | 999.00 Mn |